PNU-282987 Attenuates Intestinal Epithelial Barrier Dysfunction in LPS-Induced Endotoxemia
Overview
Pathology
Affiliations
PNU-282987, the α7 acetylcholine receptor(α7nAchR) agonist, has been repeatedly reported to play a key role in anti-inflammatory action of multiple disease. However, little is known about its effect on LPS-induced intestinal epithelial barrier dysfunction. This study investigated the protective effects and mechanisms of PNU-282987 on intestinal epithelial barrier dysfunction in lipopolysaccharide(LPS)-induced endotoxemic rats. Endotoxemia models were induced by intraperitoneal injection of 10 mg/kg LPS. In the endotoxemic group, results showed increases in ileum mucosal permeability, ultrastructural damage of tight junction and redistribution of zonula occludens-1, apoptosis of intestinal epithelial cells and caspase-3 activation. These changes were significantly improved after PNU-282987 administration(P < 0.05). Pretreatment with α-bungarotoxin before PNU-282987 administration reversed the effects of PNU-282987(P < 0.05). These results indicate that PNU-282987 exerts protective effects on intestinal epithelial barrier dysfunction in LPS-induced endotoxemic rats, and its mechanism may involve the improvement of zonula occludens-1 and inhibition of enterocyte apoptosis in an α7nAchR-dependent manner.
Kong F, Huang P, Chen J, Ma Y Reprod Sci. 2024; 31(11):3323-3333.
PMID: 38653859 DOI: 10.1007/s43032-024-01562-3.
Zagmignan A, Mendes Y, Mesquita G, Costa Dos Santos G, Dos Santos Silva L, Sales A Nutrients. 2023; 15(4).
PMID: 36839417 PMC: 9962425. DOI: 10.3390/nu15041059.
Shi X, Li J, Han Y, Wang J, Li Q, Zheng Y Bosn J Basic Med Sci. 2022; 22(6):882-893.
PMID: 35535600 PMC: 9589307. DOI: 10.17305/bjbms.2022.7111.